These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 25142862

  • 1. PSAT1 regulates cyclin D1 degradation and sustains proliferation of non-small cell lung cancer cells.
    Yang Y, Wu J, Cai J, He Z, Yuan J, Zhu X, Li Y, Li M, Guan H.
    Int J Cancer; 2015 Feb 15; 136(4):E39-50. PubMed ID: 25142862
    [Abstract] [Full Text] [Related]

  • 2. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway.
    Ong CS, Zhou J, Ong CN, Shen HM.
    Cancer Lett; 2010 Dec 08; 298(2):167-75. PubMed ID: 20655656
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy.
    Takahashi-Yanaga F, Sasaguri T.
    Cell Signal; 2008 Apr 08; 20(4):581-9. PubMed ID: 18023328
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Progesterone inhibits the estrogen-induced phosphoinositide 3-kinase-->AKT-->GSK-3beta-->cyclin D1-->pRB pathway to block uterine epithelial cell proliferation.
    Chen B, Pan H, Zhu L, Deng Y, Pollard JW.
    Mol Endocrinol; 2005 Aug 08; 19(8):1978-90. PubMed ID: 15845746
    [Abstract] [Full Text] [Related]

  • 10. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
    Lu WJ, Chua MS, Wei W, So SK.
    Oncotarget; 2015 Oct 06; 6(30):29847-59. PubMed ID: 26359353
    [Abstract] [Full Text] [Related]

  • 11. Differentiation-inducing factor-1 induces cyclin D1 degradation through the phosphorylation of Thr286 in squamous cell carcinoma.
    Mori J, Takahashi-Yanaga F, Miwa Y, Watanabe Y, Hirata M, Morimoto S, Shirasuna K, Sasaguri T.
    Exp Cell Res; 2005 Nov 01; 310(2):426-33. PubMed ID: 16153639
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of Rac1 activity induces G1/S phase arrest through the GSK3/cyclin D1 pathway in human cancer cells.
    Liu L, Zhang H, Shi L, Zhang W, Yuan J, Chen X, Liu J, Zhang Y, Wang Z.
    Oncol Rep; 2014 Oct 01; 32(4):1395-400. PubMed ID: 25109327
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Laforin negatively regulates cell cycle progression through glycogen synthase kinase 3beta-dependent mechanisms.
    Liu R, Wang L, Chen C, Liu Y, Zhou P, Wang Y, Wang X, Turnbull J, Minassian BA, Liu Y, Zheng P.
    Mol Cell Biol; 2008 Dec 01; 28(23):7236-44. PubMed ID: 18824542
    [Abstract] [Full Text] [Related]

  • 15. Gambogenic acid induces G1 arrest via GSK3β-dependent cyclin D1 degradation and triggers autophagy in lung cancer cells.
    Yu XJ, Han QB, Wen ZS, Ma L, Gao J, Zhou GB.
    Cancer Lett; 2012 Sep 28; 322(2):185-94. PubMed ID: 22410463
    [Abstract] [Full Text] [Related]

  • 16. Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice.
    Wang Y, Lam JB, Lam KS, Liu J, Lam MC, Hoo RL, Wu D, Cooper GJ, Xu A.
    Cancer Res; 2006 Dec 01; 66(23):11462-70. PubMed ID: 17145894
    [Abstract] [Full Text] [Related]

  • 17. Phosphorylation of glycogen synthase kinase-3beta at serine-9 by phospholipase Cgamma1 through protein kinase C in rat 3Y1 fibroblasts.
    Shin SY, Yoon SC, Kim YH, Kim YS, Lee YH.
    Exp Mol Med; 2002 Dec 31; 34(6):444-50. PubMed ID: 12526086
    [Abstract] [Full Text] [Related]

  • 18. Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells.
    Cao Q, Lu X, Feng YJ.
    Cell Res; 2006 Jul 31; 16(7):671-7. PubMed ID: 16788573
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.